Relevance,RGD ID,Symbol,Name,LOD,P Value,Trait,Sub Trait,Chr,Start,Stop,Species,Annotations,Match,Type 1000,2317883,Alcrsp26,Alcohol response QTL 26,1.8,0.63,response to alcohol trait (VT:0010489),duration of loss of righting reflex (CMO:0002289),3,153918022,177699992,Rat,n/a,region,qtl 1000,12879871,Am7,Aortic mass QTL 7,,0.001,aorta mass (VT:0002845),aorta weight to aorta length to body weight ratio (CMO:0002722),3,153381237,174632112,Rat,n/a,region,qtl 1000,1298068,Bp167,Blood pressure QTL 167,,0.004,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),3,150368003,177699992,Rat,n/a,region,qtl 1000,1331726,Bp208,Blood pressure QTL 208,3.129,,arterial blood pressure trait (VT:2000000),mean arterial blood pressure (CMO:0000009),3,148348517,171467264,Rat,n/a,region,qtl 1000,1598877,Bp285,Blood pressure QTL 285,1.5,0.03,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),3,128986468,173986468,Rat,n/a,region,qtl 1000,2301411,Bp320,Blood pressure QTL 320,,0.001,arterial blood pressure trait (VT:2000000),mean arterial blood pressure (CMO:0000009),3,153381237,174632112,Rat,n/a,region,qtl 1000,631541,Bp81,Blood pressure QTL 81,4,,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),3,129787213,177699992,Rat,n/a,region,qtl 1000,12879876,Bw182,Body weight QTL 182,,0.003,body mass (VT:0001259),body weight (CMO:0000012),3,153381237,174632112,Rat,n/a,region,qtl 1000,2312670,Bw94,Body weight QTL 94,,0.01,inguinal fat pad mass (VT:0010424),inguinal fat pad weight to body weight ratio (CMO:0001253),3,103141814,176418101,Rat,n/a,region,qtl 1000,70216,Cm14,Cardiac mass QTL 14,2.1,,heart mass (VT:0007028),heart wet weight (CMO:0000069),3,30846101,172879276,Rat,n/a,region,qtl 1000,12879873,Cm96,Cardiac mass QTL 96,,0.001,heart mass (VT:0007028),heart wet weight to body weight ratio (CMO:0002408),3,153381237,174632112,Rat,n/a,region,qtl 1000,12879872,Cm97,Cardiac mass QTL 97,,0.001,heart left ventricle mass (VT:0007031),heart left ventricle weight to body weight ratio (CMO:0000530),3,153381237,174632112,Rat,n/a,region,qtl 1000,12879874,Cm98,Cardiac mass QTL 98,,0.005,heart right ventricle mass (VT:0007033),heart right ventricle weight to body weight ratio (CMO:0000914),3,153381237,174632112,Rat,n/a,region,qtl 1000,10755461,Coatc16,Coat color QTL 16,,,coat/hair pigmentation trait (VT:0010463),pigmented ventral coat/hair area to total ventral coat/hair area ratio (CMO:0001812),3,130006659,175006659,Rat,n/a,region,qtl 1000,2298477,Eau4,Experimental allergic uveoretinitis QTL 4,,0.0011,uvea integrity trait (VT:0010551),experimental autoimmune uveitis score (CMO:0001504),3,146232777,177699992,Rat,n/a,region,qtl 1000,1559282,Emca5,Estrogen-induced mammary cancer QTL 5,3.9,,mammary gland integrity trait (VT:0010552),percentage of study population developing mammary tumors during a period of time (CMO:0000948),3,45406058,177699992,Rat,n/a,region,qtl 1000,2302373,Gluco39,Glucose level QTL 39,5.01,,blood glucose amount (VT:0000188),blood glucose level area under curve (AUC) (CMO:0000350),3,103141944,170934860,Rat,n/a,region,qtl 1000,631673,Iddm13,Insulin dependent diabetes mellitus QTL 13,1.3,0.663,blood glucose amount (VT:0000188),plasma glucose level (CMO:0000042),3,136876155,170935007,Rat,n/a,region,qtl 1000,9589106,Insul23,Insulin level QTL 23,13.86,0.001,blood insulin amount (VT:0001560),plasma insulin level (CMO:0000342),3,139578365,177699992,Rat,n/a,region,qtl 1000,12879875,Kidm64,Kidney mass QTL 64,,0.001,kidney mass (VT:0002707),both kidneys wet weight to body weight ratio (CMO:0000340),3,153381237,174632112,Rat,n/a,region,qtl 1000,1598854,Memor10,Memory QTL 10,2,,exploratory behavior trait (VT:0010471),average horizontal distance in proximity to the target during voluntary locomotion in an experimental apparatus (CMO:0002674),3,153412455,170534769,Rat,n/a,region,qtl 1000,8552952,Pigfal13,Plasma insulin-like growth factor 1 level QTL 13,,,blood insulin-like growth factor amount (VT:0010479),plasma insulin-like growth factor 1 level (CMO:0001299),3,148034701,177699992,Rat,n/a,region,qtl 1000,1581568,Rf53,Renal function QTL 53,,,total urine protein amount (VT:0000032),urine protein excretion rate to body weight ratio (CMO:0001099),3,58204463,170534769,Rat,n/a,region,qtl 1000,1576306,Schws3,Schwannoma susceptibility QTL 3,,0.001,nervous system integrity trait (VT:0010566),percentage of study population developing trigeminal nerve neurilemmomas during a period of time (CMO:0002017),3,125848628,170848628,Rat,n/a,region,qtl 1000,2312673,Scl63,Serum cholesterol level QTL 63,,0.001,blood cholesterol amount (VT:0000180),serum total cholesterol level (CMO:0000363),3,103141814,176418101,Rat,n/a,region,qtl 1000,2312659,Slep7,Serum leptin concentration QTL 7,,0.001,blood leptin amount (VT:0005667),serum leptin level (CMO:0000780),3,103141814,176418101,Rat,n/a,region,qtl 1000,2303620,Vencon4,Ventilatory control QTL 4,3.9,,respiration trait (VT:0001943),tidal volume (CMO:0000222),3,132875075,176418101,Rat,n/a,region,qtl 1000,8552791,Vie2,Viral induced encephalitis QTL 2,4.1,,brain integrity trait (VT:0010579),encephalitis incidence/prevalence measurement (CMO:0002361),3,153412455,177699992,Rat,n/a,region,qtl 1000,1578666,Vnigr1,Vascular neointimal growth QTL 1,4.6,,artery morphology trait (VT:0002191),artery lumen area (CMO:0001409),3,156381661,176418101,Rat,n/a,region,qtl 1000,1578656,Vnigr2,Vascular neointimal growth QTL 2,4.2,,artery morphology trait (VT:0002191),lesioned artery residual lumen area (CMO:0001417),3,138374177,177699992,Rat,n/a,region,qtl 1000,1578653,Vnigr3,Vascular neointimal growth QTL 3,3.1,,artery morphology trait (VT:0002191),artery neointimal hyperplastic lesion area (CMO:0001414),3,138374177,177699992,Rat,n/a,region,qtl